BCR-ABL1+ Acute Myeloid Leukemia: Clonal Selection of a BCR-ABL1- Subclone as a Cause of Refractory Disease with Nilotinib Treatment

Publisher： Karger

E-ISSN： 1421-9662|133|2|237-241

ISSN： 0001-5792

Source： Acta Haematologica, Vol.133, Iss.2, 2014-11, pp. : 237-241

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Role of Treatment in the Appearance and Selection of BCR-ABL1 Kinase Domain Mutations

By Razga Filip   Jurcek Tomas   Zackova Daniela   Dvorakova Dana   Toskova Martina   Jeziskova Ivana   Mayer Jiri   Racil Zdenek  

Molecular Diagnosis & Therapy, Vol. 16, Iss. 4, 2012-08 ,pp. : 251-259

Adis International

Access to resources Recommend Favorite

Occurrence of BCR-ABL1-Positive Chronic Myeloid Leukemia following Essential Thrombocythemia

By  

Acta Haematologica, Vol. 126, Iss. 4, 2011-09 ,pp. : 220-223

Karger

Access to resources Recommend Favorite

International Reporting Scale of BCR-ABL1 Fusion Transcript in Chronic Myeloid Leukemia: First Report from India

By  

Acta Haematologica, Vol. 127, Iss. 3, 2012-01 ,pp. : 135-142

Karger

Access to resources Recommend Favorite

Acute Lymphoblastic Leukaemia with an e1a3 BCR-ABL1 Fusion

By  

Acta Haematologica, Vol. 126, Iss. 4, 2011-09 ,pp. : 214-215

Karger

Access to resources Recommend Favorite

BCR/ABL1 Kinase Domain Mutation Monitoring: Could Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Benefit As Well?

By  

Acta Haematologica, Vol. 134, Iss. 2, 2015-04 ,pp. : 69-70

Karger

Access to resources Recommend Favorite